High correlation between in vivo [123I]β-CIT SPECT/CT imaging and post-mortem immunohistochemical findings in the evaluation of lesions induced by 6-OHDA in rats

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-10

  Bäck, Susanne ^a   Raki, Mari ^a   Tuominen, Raimo K ^a   Raasmaja, Atso ^a   Bergström, Kim ^a   Männistö, Pekka T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

6 OHDA; Rat; SPECT; CIT

Indexed keywords

AMPHETAMINE; IOMETOPANE I 123; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN ASYMMETRY; CORPUS STRIATUM; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOLOGY; SUBSTANTIA NIGRA PARS COMPACTA;

EID: 84881240915     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-46     Document Type: Article

References (38)

1. Dauer W, Przedborski S: Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
2. Ungerstedt U: 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968, 5:107-110.
3. Ungerstedt U, Arbuthnott GW: Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970, 24:485-493.
4. Schwarting RK, Huston JP: The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol 1996, 50:275-331.
5. Schwarting RK, Huston JP: Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae. Prog Neurobiol 1996, 49:215-266.
6. Kirik D, Rosenblad C, Björklund A: Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 1998, 152:259-277.
7. Deumens R, Blokland A, Prickaerts J: Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 2002, 175:303-317.
8. Sauer H, Oertel WH: Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994, 59:401-415.
9. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain. J Med Chem 1991, 34:3144-3146.
10. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S: Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A 1993, 90:11965-11969.
11. Cass WA, Zahniser NR, Flach KA, Gerhardt GA: Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors. J Neurochem 1993, 61:2269-2278.
12. Lorang D, Amara SG, Simerly RB: Cell-type-specific expression of catecholamine transporters in the rat brain. J Neurosci 1994, 14:4903-4914.
13. Booij J, de Bruin K, Habraken JB, Voorn P: Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography. Eur J Nucl Med 2002, 29:1221-1224.
14. 123I]CIT pinhole SPECT. NeuroImage 2002, 17:128-141.
15. Van Camp N, Vreys R, Van Laere K, Lauwers E, Beque D, Verhoye M, Casteels C, Verbruggen A, Debyser Z, Mortelmans L, Sijbers J, Nuyts J, Baekelandt V, Van der Linden A: Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with microSPECT and quantitative MRI. MAGMA 2010, 23:65-75.
16. Hume SP, Lammertsma AA, Myers R, Rajeswaran S, Bloomfield PM, Ashworth S, Fricker RA, Torres EM, Watson I, Jones T: The potential of high-resolution positron emission tomography to monitor striatal dopaminergic function in rat models of disease. J Neurosci Methods 1996, 67:103-112.
17. Chen YC, Galpern WR, Brownell AL, Matthews RT, Bogdanov M, Isacson O, Keltner JR, Beal MF, Rosen BR, Jenkins BG: Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data. Magn Reson Med 1997, 38:389-398.
18. Nguyen TV, Brownell AL, Iris Chen YC, Livni E, Coyle JT, Rosen BR, Cavagna F, Jenkins BG: Detection of the effects of dopamine receptor supersensitivity using pharmacological MRI and correlations with PET. Synapse 2000, 36:57-65.
19. Cicchetti F, Brownell AL, Williams K, Chen YI, Livni E, Isacson O: Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci 2002, 15:991-998.
20. Inaji M, Okauchi T, Ando K, Maeda J, Nagai Y, Yoshizaki T, Okano H, Nariai T, Ohno K, Obayashi S, Higuchi M, Suhara T: Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats. Brain Res 2005, 1064:136-145.
21. Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL: Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats. J Nucl Med 2007, 48:1147-1153.
22. Zhu A, Wang X, Yu M, Wang JQ, Brownell AL: Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies. J Cereb Blood Flow Metab 2007, 27:1623-1631.
23. Nikolaus S, Larisch R, Vosberg H, Beu M, Hautzel H, Wirrwar A, Mueller HW, Antke C: In vivo imaging neurotransmitter function. The rat 6-hydroxydopamine model and its relevance for human Parkinson's disease. Nuklearmedizin 2011, 50:155-166.
24. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. San Diego: Academic Press; 1997.
25. Kyono K, Takashima T, Katayama Y, Kawasaki T, Zochi R, Gouda M, Kuwahara Y, Takahashi K, Wada Y, Onoe H, Watanabe Y: Use of [18F]FDOPA-PET for in vivo evaluation of dopaminergic dysfunction in unilaterally 6-OHDAlesioned rats. EJNMMI Res 2011, 1:25. doi:10.1186/2191-219X-1-25.
26. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F: Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 1973, 20:415-455.
27. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM: Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 1990, 13:290-296.
28. 18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease. Synapse 2004, 51:119-127.
29. Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L: In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain. Eur J Nucl Med 1997, 24:596-601.
30. Booij J, Knol RJ, Reneman L, de Bruin K, Janssen AG, van Royen EA: Iodine-123 labelled nor-beta-CIT binds to the serotonin transporter in vivo as assessed by biodistribution studies in rats. Eur J Nucl Med 1998, 25:1666-1669.
31. Sun W, Sugiyama K, Fang X, Yamaguchi H, Akamine S, Magata Y, Namba H: Different striatal D2-like receptor function in an early stage after unilateral striatal lesion and medial forebrain bundle lesion in rats. Brain Res 2010, 1317:227-235.
32. 18F]-ADAM in a Parkinsonian rat model. Cell Transplant. in press.
33. 11C-methylphenidate PET. J Nucl Med 2012, 53:813-822.
34. Kim SR, Chen X, Oo TF, Kareva T, Yarygina O, Wang C, During M, Kholodilov N, Burke RE: Dopaminergic pathway reconstruction by Akt/Rheb-induced axon regeneration. Ann Neurol 2011, 70:110-120.
35. Marti MJ, Saura J, Burke RE, Jackson-Lewis V, Jimenez A, Bonastre M, Tolosa E: Striatal 6-hydroxydopamine induces apoptosis of nigral neurons in the adult rat. Brain Res 2002, 958:185-191.
36. Pitkonen M, Hippeläinen E, Raki M, Andressoo J-O, Urtti A, Männistö PT, Savolainen S, Saarma M, Bergström K: Advanced brain dopamine transporter imaging in mice using small animal SPECT/CT. EJNMMI Res 2012, 2:55. doi:10.1186/2191-219X-2-55.
37. Meredith GE, Kang UJ: Behavioral models of Parkinson's disease in rodents: a new look at an old problem. Mov Disord 2006, 21:1595-1606.
38. Cheng HC, Ulane CM, Burke RE: Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 2010, 67:715-725.